Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia (2021)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; TRAINA, FABÍOLA - FMRP ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; SILVA, JEAN CARLOS LIPRERI DA - ICB ; SILVA, JUAN LUIZ COELHO DA - FMRP ; VICARI, HUGO PASSOS - ICB
- Unidades: ICB; FMRP
- DOI: 10.1007/s13402-021-00621-0
- Subjects: FARMACOLOGIA; LEUCEMIA MIELOIDE AGUDA; ANTINEOPLÁSICOS; CITOESQUELETO; EXPRESSÃO GÊNICA; GENÔMICA; TRANSDUÇÃO DE SINAL CELULAR
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Cellular Oncology
- ISSN: 2211-3436
- Volume/Número/Paginação/Ano: v. 44, n. 5, p. 1105-1117, 2021
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Jean Carlos Lipreri da et al. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cellular Oncology, v. 44, n. 5, p. 1105-1117, 2021Tradução . . Disponível em: https://doi.org/10.1007/s13402-021-00621-0. Acesso em: 27 dez. 2025. -
APA
Silva, J. C. L. da, Silva, J. L. C., Lima, K., Vicari, H. P., Lazarini, M., Costa-Lotufo, L. V., et al. (2021). Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cellular Oncology, 44( 5), 1105-1117. doi:10.1007/s13402-021-00621-0 -
NLM
Silva JCL da, Silva JLC, Lima K, Vicari HP, Lazarini M, Costa-Lotufo LV, Traina F, Machado Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia [Internet]. Cellular Oncology. 2021 ; 44( 5): 1105-1117.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s13402-021-00621-0 -
Vancouver
Silva JCL da, Silva JLC, Lima K, Vicari HP, Lazarini M, Costa-Lotufo LV, Traina F, Machado Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia [Internet]. Cellular Oncology. 2021 ; 44( 5): 1105-1117.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s13402-021-00621-0 - Inibição farmacológica de ezrina reduz a viabilidade, a clonogenicidade e a ativação da via PI3K/AKT/mTOR em modelos celulares de leucemia mieloide aguda
- Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
- Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
- Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
- Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms
- Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia
- STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells
- Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2V617F cells
- CDC7 (cell division cycle 7)
Informações sobre o DOI: 10.1007/s13402-021-00621-0 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003035490.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
